Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

The Epstein–Barr virus oncoprotein latent infection membrane protein 1 (LMP1) is a constitutively aggregated pseudo-tumor necrosis factor receptor (TNFR) that activates transcription factor NF-κB through two sites in its C-terminal cytoplasmic domain. One site is similar to activated TNFRII in associating with TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD. TNFRI has been recently shown to activate NF-κB through association with TRADD, RIP, and TRAF2; activation of the NF-κB-inducing kinase (NIK); activation of the IκBα kinases (IKKα and IKKβ); and phosphorylation of IκBα. IκBα phosphorylation on Ser-32 and Ser-36 is followed by its degradation and NF-κB activation. In this report, we show that NF-κB activation by LMP1 or by each of its effector sites is mediated by a pathway that includes NIK, IKKα, and IKKβ. Dominant negative mutants of NIK, IKKα, or IKKβ substantially inhibited NF-κB activation by LMP1 or by each of its effector sites.

Bibliography

Sylla, B. S., Hung, S. C., Davidson, D. M., Hatzivassiliou, E., Malinin, N. L., Wallach, D., Gilmore, T. D., Kieff, E., & Mosialos, G. (1998). Epstein–Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ. Proceedings of the National Academy of Sciences, 95(17), 10106–10111.

Authors 9
  1. Bakary S. Sylla (first)
  2. Siu Chun Hung (additional)
  3. David M. Davidson (additional)
  4. Eudoxia Hatzivassiliou (additional)
  5. Nikolai L. Malinin (additional)
  6. David Wallach (additional)
  7. Thomas D. Gilmore (additional)
  8. Elliott Kieff (additional)
  9. George Mosialos (additional)
References 41 Referenced 129
  1. 10.1073/pnas.90.19.9150
  2. E Kieff in Fields Virology, eds B N Fields, D M Knipe, P M Howley (Lippincott-Raven, Philadelphia), pp. 2343–2396 (1996). / in Fields Virology by Kieff E (1996)
  3. 10.1016/S0021-9258(18)35741-7
  4. 10.1128/jvi.69.5.2968-2976.1995
  5. D S Huen, S A Henderson, C D Croom, M Rowe Oncogene 10, 549–560 (1995). / Oncogene by Huen D S (1995)
  6. E Hatzivassiliou, W E Miller, N Raab-Traub, E Kieff, G Mosialos J Immunol 160, 1116–1121 (1998). (10.4049/jimmunol.160.3.1116) / J Immunol by Hatzivassiliou E (1998)
  7. 10.1093/emboj/16.21.6478
  8. 10.1038/sj.onc.1201694
  9. 10.1016/0092-8674(85)90256-9
  10. 10.1128/jvi.62.7.2337-2346.1988
  11. V R Baichwal, B Sugden Oncogene 4, 67–74 (1989). / Oncogene by Baichwal V R (1989)
  12. 10.1016/0092-8674(95)90489-1
  13. 10.1128/MCB.16.12.7098
  14. 10.1073/pnas.94.23.12592
  15. 10.1128/jvi.68.7.4369-4376.1994
  16. 10.1128/jvi.66.7.4612-4616.1992
  17. 10.1128/jvi.69.2.675-683.1995
  18. 10.1073/pnas.93.20.11085
  19. 10.1073/pnas.94.4.1447
  20. 10.1038/sj.onc.1201359
  21. 10.1016/0092-8674(95)90415-8
  22. 10.1038/385540a0
  23. 10.1016/S0092-8674(00)80344-X
  24. 10.1126/science.278.5339.866
  25. 10.1038/41493
  26. 10.1126/science.278.5339.860
  27. 10.1016/S0092-8674(00)80406-7
  28. 10.1128/jvi.71.1.586-594.1997
  29. 10.1016/S0092-8674(00)81064-8
  30. 10.1016/S0092-8674(00)80413-4
  31. 10.1016/S0021-9258(18)42833-5
  32. 10.1016/0092-8674(95)90070-5
  33. 10.1016/S1074-7613(00)80252-6
  34. 10.1002/j.1460-2075.1996.tb01007.x
  35. 10.1016/S1074-7613(00)80535-X
  36. 10.1073/pnas.95.7.3792
  37. 10.1073/pnas.95.7.3537
  38. 10.1016/0092-8674(94)90532-0
  39. 10.1126/science.7544915
  40. 10.1074/jbc.270.8.3574
  41. 10.1074/jbc.272.18.12069
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:42 a.m.)
Deposited 2 years, 4 months ago (April 22, 2023, 8:29 a.m.)
Indexed 3 months ago (May 26, 2025, 1:23 a.m.)
Issued 27 years ago (Aug. 18, 1998)
Published 27 years ago (Aug. 18, 1998)
Published Online 27 years ago (Aug. 18, 1998)
Published Print 27 years ago (Aug. 18, 1998)
Funders 0

None

@article{Sylla_1998, title={Epstein–Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ}, volume={95}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.95.17.10106}, DOI={10.1073/pnas.95.17.10106}, number={17}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Sylla, Bakary S. and Hung, Siu Chun and Davidson, David M. and Hatzivassiliou, Eudoxia and Malinin, Nikolai L. and Wallach, David and Gilmore, Thomas D. and Kieff, Elliott and Mosialos, George}, year={1998}, month=aug, pages={10106–10111} }